Baillie Gifford & Co. Sells 3,104 Shares of Exelon Co. (NASDAQ:EXC)

Baillie Gifford & Co. reduced its position in shares of Exelon Co. (NASDAQ:EXCFree Report) by 3.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 92,534 shares of the company’s stock after selling 3,104 shares during the period. Baillie Gifford & Co.’s holdings in Exelon were worth $3,752,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Foundations Investment Advisors LLC boosted its holdings in shares of Exelon by 3.5% in the 3rd quarter. Foundations Investment Advisors LLC now owns 7,533 shares of the company’s stock worth $305,000 after acquiring an additional 255 shares in the last quarter. Harbor Capital Advisors Inc. grew its holdings in shares of Exelon by 1.0% during the third quarter. Harbor Capital Advisors Inc. now owns 28,392 shares of the company’s stock worth $1,151,000 after purchasing an additional 274 shares during the last quarter. Black Diamond Financial LLC raised its holdings in shares of Exelon by 2.0% in the second quarter. Black Diamond Financial LLC now owns 14,067 shares of the company’s stock valued at $487,000 after buying an additional 279 shares during the last quarter. Ballentine Partners LLC lifted its position in Exelon by 2.1% during the 3rd quarter. Ballentine Partners LLC now owns 13,922 shares of the company’s stock worth $565,000 after buying an additional 285 shares in the last quarter. Finally, Aptus Capital Advisors LLC grew its holdings in Exelon by 3.3% during the 2nd quarter. Aptus Capital Advisors LLC now owns 9,412 shares of the company’s stock worth $326,000 after acquiring an additional 304 shares during the last quarter. 80.92% of the stock is currently owned by institutional investors and hedge funds.

Exelon Trading Down 0.1 %

EXC opened at $38.14 on Thursday. The firm’s fifty day moving average is $39.69 and its two-hundred day moving average is $37.77. The firm has a market cap of $38.32 billion, a PE ratio of 15.65, a price-to-earnings-growth ratio of 2.72 and a beta of 0.54. Exelon Co. has a twelve month low of $33.35 and a twelve month high of $41.42. The company has a debt-to-equity ratio of 1.66, a quick ratio of 0.97 and a current ratio of 1.09.

Exelon (NASDAQ:EXCGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.71 EPS for the quarter, topping the consensus estimate of $0.67 by $0.04. Exelon had a return on equity of 9.47% and a net margin of 10.60%. The business had revenue of $6.15 billion for the quarter, compared to the consensus estimate of $5.85 billion. During the same quarter last year, the business posted $0.67 EPS. The firm’s revenue was up 2.9% compared to the same quarter last year. Equities research analysts anticipate that Exelon Co. will post 2.45 EPS for the current year.

Exelon Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Monday, November 11th will be paid a dividend of $0.38 per share. The ex-dividend date is Friday, November 8th. This represents a $1.52 dividend on an annualized basis and a yield of 3.99%. Exelon’s payout ratio is 62.55%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on EXC shares. Wells Fargo & Company upped their target price on shares of Exelon from $40.00 to $42.00 and gave the stock an “equal weight” rating in a research report on Friday, August 2nd. Scotiabank increased their price objective on Exelon from $37.00 to $40.00 and gave the company a “sector perform” rating in a research report on Tuesday, August 20th. Barclays lifted their target price on Exelon from $41.00 to $44.00 and gave the company an “overweight” rating in a research note on Tuesday, October 15th. Jefferies Financial Group started coverage on Exelon in a report on Thursday, September 19th. They issued a “buy” rating and a $46.00 price target on the stock. Finally, Morgan Stanley boosted their price objective on Exelon from $42.00 to $45.00 and gave the stock an “equal weight” rating in a report on Wednesday, September 25th. Eleven equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $41.33.

View Our Latest Stock Analysis on Exelon

About Exelon

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Featured Articles

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NASDAQ:EXCFree Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.